scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0278-5846(01)80005-1 |
P698 | PubMed publication ID | 11294488 |
P50 | author | Nobuyuki Okamura | Q43233931 |
P2093 | author name string | Higuchi M | |
Takeda A | |||
Itoh M | |||
Matsui T | |||
Sasaki H | |||
Arai H | |||
Tashiro M | |||
Hu XS | |||
P2860 | cites work | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
Statistical parametric maps in functional imaging: A general linear approach | Q27864122 | ||
Diagnosing dementia with Lewy bodies | Q33751527 | ||
Cholinesterase inhibitors: A new class of psychotropic compounds | Q33807472 | ||
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop | Q34736093 | ||
Diffuse Lewy body disease in Japan | Q37941288 | ||
Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease | Q41354157 | ||
Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease | Q42458585 | ||
Cognitive decline is faster in Lewy body variant than in Alzheimer's disease | Q43770335 | ||
Autosomal dominant Lewy body parkinsonism in a four-generation family | Q46179622 | ||
Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies | Q48392838 | ||
Performance evaluation of a large axial field-of-view PET scanner: SET-2400W. | Q48538636 | ||
Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. | Q53222178 | ||
Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. | Q53335020 | ||
Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. | Q53340013 | ||
Spatial registration and normalization of images | Q57004421 | ||
Clinical features of familial diffuse Lewy body disease | Q67218945 | ||
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. | Q67234444 | ||
P433 | issue | 2 | |
P921 | main subject | dementia | Q83030 |
Alzheimer's disease | Q11081 | ||
dementia with Lewy bodies | Q101245788 | ||
P304 | page(s) | 447-456 | |
P577 | publication date | 2001-02-01 | |
P1433 | published in | Progress in Neuro-Psychopharmacology & Biological Psychiatry | Q15616665 |
P1476 | title | [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease | |
P478 | volume | 25 |
Q34113084 | (99m)Tc-hexamethyl propyleneamine oxime brain perfusion single photon emission computed tomography in characterization of dementia: an initial experience in Indian clinical practice |
Q31033082 | Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia |
Q43233891 | Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET. |
Q37756103 | Autopsy as gold standard in FDG-PET studies in dementia. |
Q39440179 | Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases |
Q53513882 | Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia. |
Q53269086 | Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT. |
Q37329050 | Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study |
Q35692950 | Imaging Alzheimer's disease: clinical applications |
Q48189574 | Metabolic correlates of brain reserve in dementia with Lewy bodies: an FDG PET study. |
Q64446743 | Neuroimaging in Dementia |
Q30756562 | Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology |
Q57813333 | The relationship between hallucinations and FDG-PET in dementia with Lewy bodies |
Q51906039 | Utility of the Bender Gestalt Test for differentiation of dementia with Lewy bodies from Alzheimer's disease in patients showing mild to moderate dementia. |
Q50725111 | Verbal and nonverbal learning and recall in dementia with lewy bodies and Alzheimer's disease. |
Q31108303 | [Molecular imaging in neurological diseases]. |
Search more.